Information Library

Results for: Business transformation - Cost control/reduction - Product Development & Commercialization

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Consulting – Breakthrough Thinking Built on Experience

    Brochure — November 23, 2010
    Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today.

  • Outsourcing as strategic alternative to your own headcount

    Presentation — May 25, 2010
    Approach of Roche Italy in outsourcing their primary care sales force to Quintiles

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • QUINTILES EXAMINES ASIA-PACIFIC DRUG DEVELOPMENT LANDSCAPE IN NEW REPORT

    Press Release — March 17, 2010 - A new report from Quintiles analyzes the Asia-Pacific pharmaceutical development landscape and its evolution from outsourcing destination to potential innovation hub.

  • QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE

    Press Release — November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.

  • Anatomy of a Managed Partnership

    Hear from the Experts — May 26, 2009
    Partnering affords pharma the opportunity to bolster development pipelines without taking on additional risk or adding to fixed costs.

  • Jim Featherstone, Ph.D.

    Hear from the Experts — March 25, 2009
    Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice.

  • Matthew Eberhart

    Hear from the Experts — March 25, 2009
    Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.

  • Gain Capital & Retain Value

    Case Study — March 24, 2009
    Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product.

Page 1 of 1 (9 results)

Subscribe to Email Based on Your Interests

Set preferences